| Line 7: |
Line 7: |
| | *Bile duct hyperplasia | | *Bile duct hyperplasia |
| | | | |
| − | '''Bile duct hyperplasia''' around portal regions is a non-specific response to a variety of long-standing hepatic insults, but occurs especially in association with diseases that [[Biliary Tract - Obstruction|obstruct bile drainage]]. | + | '''Bile duct hyperplasia''' around portal regions is a non-specific response to a variety of long-standing hepatic insults, but occurs especially in association with diseases that [[Biliary Tract Obstruction|obstruct bile drainage]]. |
| | | | |
| | '''Vascular abnormalities''' are also associated with cirrhosis. Anastomoses occur between the hepatic portal vein and systemic vasculature due to increased portal pressure. Additionally, [[Portosystemic Shunt|vascular shunts]] can result within regenerative nodules, either between central and portal veins, or between hepatic arteries and central veins. | | '''Vascular abnormalities''' are also associated with cirrhosis. Anastomoses occur between the hepatic portal vein and systemic vasculature due to increased portal pressure. Additionally, [[Portosystemic Shunt|vascular shunts]] can result within regenerative nodules, either between central and portal veins, or between hepatic arteries and central veins. |
| Line 17: |
Line 17: |
| | **[[Hepatitis, Lobular Dissecting|Lobular dissecting hepatitis in dogs]] | | **[[Hepatitis, Lobular Dissecting|Lobular dissecting hepatitis in dogs]] |
| | **Hepatitis due to [[Infectious Canine Hepatitis|infectious canine hepatitis virus]] | | **Hepatitis due to [[Infectious Canine Hepatitis|infectious canine hepatitis virus]] |
| − | *Chronic [[cholangitis]] or [[Biliary Tract - Obstruction|bile duct obstruction]] | + | *Chronic [[cholangitis]] or [[Biliary Tract Obstruction|bile duct obstruction]] |
| | *Chronic toxicity | | *Chronic toxicity |
| | **[[Ragwort Toxicity|Pyrrolizidine alkaloid plants]] in herbivores | | **[[Ragwort Toxicity|Pyrrolizidine alkaloid plants]] in herbivores |
| Line 26: |
Line 26: |
| | | | |
| | Cirrhosis is usually the end result of multiple pathological processes, in particular cell death and active inflammation with fibrosis. Regardless of the original underlying aetiology, however, the end-stage liver can no longer perform its functions, and is therefore associated with clinical manifestations of [[Liver Failure|hepatic failure]]. | | Cirrhosis is usually the end result of multiple pathological processes, in particular cell death and active inflammation with fibrosis. Regardless of the original underlying aetiology, however, the end-stage liver can no longer perform its functions, and is therefore associated with clinical manifestations of [[Liver Failure|hepatic failure]]. |
| | + | |
| | + | {{Learning |
| | + | |Vetstream = [https://www.vetstream.com/canis/search?s=cirrhosis Cirrhosis] |
| | + | }} |
| | | | |
| | ==References == | | ==References == |
| Line 39: |
Line 43: |
| | | | |
| | | | |
| − | | + | {{Nicky Parry |
| | + | |date = 22 August 2011 |
| | + | }} |
| | | | |
| | [[Category:Liver_-_General_Pathology]] | | [[Category:Liver_-_General_Pathology]] |
| − | [[Category:Nicola Parry reviewing]] | + | [[Category:Nicola Parry reviewed]] |